Siga reports financial results for three months ended march 31, 2025

Received $26 million iv tpoxx procurement order from the u.s. government in march $94 million in tpoxx orders (to be delivered to u.s. strategic national stockpile) outstanding as of march 31, 2025 corporate update conference call today at 4:30 pm et new york, may 08, 2025 (globe newswire) -- siga technologies, inc. (siga) (nasdaq: siga), a commercial-stage pharmaceutical company, today reported financial results for the three months ended march 31, 2025. “siga has carried its momentum from 2024 into 2025, achieving steady progress on its key initiatives,” stated diem nguyen, chief executive officer.
SIGA Ratings Summary
SIGA Quant Ranking